You know that song, “It’s the Most Wonderful Time of the Year”?For many of us, it’s not about the Christmas season. It’s about a season that begins tonight.Because tonight the NFL season kicks off (Broncos versus Panthers, 8:30 p.m. on NBC).Look, I love baseball; its near-daily games are stitched into… Read More

If you haven’t seen one of the 3,000 headlines proclaiming Labor Day is the real start of the presidential campaign, congratulations. You’ve been spared a potentially painful palm slap to your own forehead.It’s only starting now?This endless campaign has lasted so long that political junkies are starting to host nostalgic… Read More

The August jobs report released this morning was one of the most hotly anticipated all year.That’s because the scores of analysts, economists, reporters and pundits whose own jobs involve opining on jobs reports want to devour it, issue their opinions quickly—and skip town for the long weekend.But investors want to… Read More

Will the Fed raise interest rates in September?Don’t bet on it.Fed leaders are supposed to focus on only two goals: maximizing employment and minimizing inflation. That’s it. That’s their job.But Fed leaders always – always – have an eye on their reputation, and the Fed’s isn’t so hot right now. Read More

For drugmakers, the best way to pick up steam is to buy smaller companies. Read More

Steve Jobs once said that he wanted to “make a dent in the universe.” The legendary founder and CEO of Apple (NASDAQ: AAPL) certainly dinged the cosmos, by creating astonishing products that transformed our lives. In the process, he helped make a lot of people rich. Since Apple went public… Read More

Army sergeant Theresa Hannigan was left paralyzed by an autoimmune disease.Each day was a struggle…She was unable to walk, and confined to a wheelchair.But her life changed for the better almost immediately when she began testing an emerging technology called an “exoskeleton” at her local VA hospital.“There are so many… Read More

As we discussed yesterday, the math behind “asymmetric” investing is compelling… Perhaps the sector that’s most illustrative of its effectiveness is biotechnology. Let’s consider a hypothetical portfolio comprised of three well-known Big Pharma stocks: Pfizer (NYSE: PFE), Merck (NYSE: MRK), and Abbott Laboratories (NYSE: ABT). Scrutinizing their fundamentals (balance… Read More

The following is an interview with Dr. Joe Duarte, a medical doctor and veteran investor with decades of experience following medical technology innovation. We sat down to discuss the virtual and augmented reality sector, where Dr. Joe and the team at Breakthrough Tech Profits recently made a trio of investment… Read More

Oil prices are plunging and yet solar power continues to thrive. We explain the dynamics behind solar’s inexorable rise Read More